title: Weight change as a predictor of incidence and remission of insulin resistance.
abstract: OBJECTIVE
  The objective of this study was to assess the longitudinal relationship of weight change on incidence and remission of insulin resistance (IR).
  
  
  METHODS
  We performed a cohort study in apparently healthy Korean men, 30 to 59 years of age, who underwent a health checkup and were followed annually or biennially between 2002 and 2009. The computer model of homeostasis model assessment, HOMA2-IR, was obtained at each visit, and IR was defined as HOMA2-IR ≥75th percentile.
  
  
  RESULTS
  For IR development, 1,755 of the 6,612 IR-free participants at baseline developed IR (rate 5.1 per 100 person-years) during 34,294.8 person-years of follow-up. The hazard ratios (95% confidence intervals) for incident IR with weight changes of <-0.9 kg, 0.6-2.1 kg and ≥2.2 kg from visit 1 to visit 2 (average 1.8 years) compared to weight change of -0.9-0.5 kg (reference) were 0.78 (0.68-0.90), 1.19 (1.04-1.35) and 1.26 (1.11-1.44), respectively. This association persisted in normal-weight individuals or those without any metabolic syndrome traits and remained significant after introducing weight categories and confounders as time-dependent exposures (P-trend <0.001). For IR remission, 903 of 1,696 IR participants had no IR (remission rate 10.3 per 100 person-years) during 8,777.4 person-years of follow-up. IR remission decreased with increasing quartiles of weight change (P-trend <0.001) and this association persisted in normal-weight individuals.
  
  
  CONCLUSIONS
  Weight gain was associated with increased IR development and decreased IR remission regardless of baseline BMI status. Preventing weight gain, even in healthy and normal-weight individuals, is an important strategy for reducing IR and its associated consequences.
authors.affiliation: Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, Korea.
authors.forename: Yoosoo
authors.initials: Y
authors.lastname: Chang
authors.forename: Eunju
authors.initials: E
authors.lastname: Sung
authors.forename: Kyung Eun
authors.initials: KE
authors.lastname: Yun
authors.forename: Hyun-Suk
authors.initials: HS
authors.lastname: Jung
authors.forename: Chan-Won
authors.initials: CW
authors.lastname: Kim
authors.forename: Min-Jung
authors.initials: MJ
authors.lastname: Kwon
authors.forename: Sung-Il
authors.initials: SI
authors.lastname: Cho
authors.forename: Seungho
authors.initials: S
authors.lastname: Ryu
mesh_terms: D000328:Adult; D015992:Body Mass Index; D001835:Body Weight / Q000502:physiology*; D015331:Cohort Studies; D006801:Humans; D015994:Incidence; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance / Q000502:physiology*; D007723:Korea; D008297:Male; D024821:Metabolic Syndrome / Q000378:metabolism / Q000503:physiopathology
chemical_list: D007328:Insulin